Financial News

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Medipharm Labs Corp (OP:MEDIF)

0.0539 UNCHANGED
Streaming Delayed Price Updated: 3:35 PM EDT, Jun 4, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open -
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.0539
Today's Range 0.0539 - 0.0539
52wk Range 0.0374 - 0.0850
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
MediPharm Labs Closes $4.5 Million Sale of Hope, BC Facility and Announces Plans to Expand EU GMP Cultivation Capacity at Napanee Facility
From MediPharm Labs Corp.
Via GlobeNewswire
Leading Independent Proxy Advisor ISS Recommends that Shareholders Vote the GREEN proxy FOR ALL MediPharm Director Nominees; REJECTS Apollo’s Arguments and Director Slate
ISS concludes that Apollo “has not presented a compelling case for change” 
From MediPharm Labs Corp.
Via GlobeNewswire

Performance

YTD
+26.5%
+26.5%
1 Month
-4.4%
-4.4%
3 Month
+18.5%
+18.5%
6 Month
+11.6%
+11.6%
1 Year
-6.7%
-6.7%

More News

Read More
MEDIF Stock Earnings: MediPharm Labs Reported Results for Q2 2024
Via InvestorPlace
MEDIF Stock Earnings: MediPharm Labs Reported Results for Q1 2024
Via InvestorPlace
MEDIF Stock Earnings: MediPharm Labs Reported Results for Q4 2023
Via InvestorPlace
MediPharm Labs Refuses to Answer Direct Questions Regarding Credible Securities Fraud Allegations Says Apollo Capital
From Apollo Technology Capital Corporation
Via GlobeNewswire
MediPharm Labs Responds to Fabricated Allegations from Dissident Shareholder
From MediPharm Labs Corp.
Via GlobeNewswire
Alleged Securities Fraud at MediPharm Labs Says Apollo Capital
From Apollo Technology Capital Corporation
Via GlobeNewswire
MediPharm Labs Board Issues Letter to Shareholders in Response to Inadequate Dissident Plan
From MediPharm Labs Corp.
Via GlobeNewswire
Apollo Capital Calls Out MediPharm Chairman Chris Taves (Managing Director, BMO Capital Markets) for Failure to Properly Communicate to Shareholders Details of David Pidduck’s Past as CEO and VP of Marketing for OxyContin® Manufacturer Purdue Pharma
From Apollo Technology Capital Corporation
Via GlobeNewswire
MediPharm Labs Begins Production of First Order for International Expansion of Novel Cannabis Metered Dose Portfolio in the EU and United Kingdom Under Blackpoint Sales and Distribution Agreement
From MediPharm Labs Corp.
Via GlobeNewswire
MediPharm Labs Cautions Shareholders about Dissident Nominees’ Governance Failures at Check-Cap Ltd.
From MediPharm Labs Corp.
Via GlobeNewswire
Apollo Capital Comments on MediPharm Labs’ Failure to Respond to Reasonable Offer to Ensure Fair, Lawful and Transparent 2025 Annual Meeting
From Apollo Technology Capital Corporation
Via GlobeNewswire
MediPharm Achieves Key Milestone Toward $4.5 Million Cash Sale of Hope Facility, On Track to Close in June
From MediPharm Labs Corp.
Via GlobeNewswire
MediPharm Labs Alerts Shareholders to Allegations Made Against Regan McGee in Multiple Litigation Filings
From MediPharm Labs Corp.
Via GlobeNewswire
This Week In Cannabis: Trump Policy Updates, Corporate Moves, Regulatory Shifts And Product Innovations
Via Benzinga
Topics Government
Exposures Political
CBD Pharma Co. MediPharm: 37% Increase In Q3 International Sales, 15% YoY Revenue Growth
Via Benzinga
MediPharm Q2 Loss Narrows, Adjusted EBITDA Climbs As Gross Profit Improves Nearly 300% YoY
Via Benzinga
Topics Cannabis
Exposures Cannabis
The Canadian Cannabis Report- Monday, Aug 12
Via Talk Markets
Topics Cannabis
Exposures Cannabis
This Cannabis Co With Significant Growth Potential And Other Hot Weed Stocks Soon To Report Earnings, What Investors Need To Know Now
Via Benzinga
Topics Cannabis
Exposures Cannabis
Executive Changes In Cannabis Industry You Should Know About, New Appointments & More
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabinoids-Focused MediPharm Boasts This Advanced Medical Cannabis Delivery Method
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabinoids-Focused Pharma Company, MediPharm, Sees Higher Q1 Revenue, CFO Touts 'Strong Financial Position'
Via Benzinga
The Canadian Cannabis Report - Monday, April 22
Via Talk Markets
Topics Cannabis
Exposures Cannabis
This Cannabinoids-Focused Pharma Co. Sees 50% YoY Surge In Revenue In 2023, Trims Losses
Via Benzinga

Frequently Asked Questions

Is Medipharm Labs Corp publicly traded?
Yes, Medipharm Labs Corp is publicly traded.
What exchange does Medipharm Labs Corp trade on?
Medipharm Labs Corp trades on the OTC Traded
What is the ticker symbol for Medipharm Labs Corp?
The ticker symbol for Medipharm Labs Corp is MEDIF on the OTC Traded
What is the current price of Medipharm Labs Corp?
The current price of Medipharm Labs Corp is 0.0539
When was Medipharm Labs Corp last traded?
The last trade of Medipharm Labs Corp was at 06/04/25 03:35 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback